Zelira Therapeutics (AU:ZLD) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zelira Therapeutics Limited has announced the issuance of 3.5 million unquoted convertible notes as part of previously disclosed transactions. These securities are not intended to be quoted on the Australian Securities Exchange. Investors may find this development indicative of the company’s strategic financial maneuvers.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.